Exchange: NASDAQ·Updated 04:10 PM EDT
TCRT logo

TCRT Alaunos Therapeutics Inc

$1.65
$0.02
(1.20%)
Today
Closed $1.65
$0.00
(0.00%)
After Hours
Reported EarningsNov 14
Mkt Cap$4.24M
Vol2,705.00

About TCRT

Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy. The company was founded in 2003 and is headquartered in Fort Lauderdale, FL.
47

Neutral Sentiment

How do you feel about TCRT?

Advertisement|Remove ads.